Evidence map›Paper›PMID 29798596›Full record

ArticleZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery2017

[Radiological evaluation of dextran sulfate/recombinant human bone morphogenetic protein 2/chitosan composite microspheres combined with coral hydroxyapatite artificial bone in repairing large segmental bone defects].

Zepeng Chen, Ying Zhang, Zefeng Lin, Xiangling Ye, Yongqiang Zhang, Yuanjun Xia, Hong Xia, Qingshui Yin

Open access · greenAbstract read
In one paragraph

Article in Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zepeng ChenOrthopedic Hospital, Guangzhou General Hospital of Chinese PLA, Guangzhou Guangdong, 510010, P.R.China.
Ying ZhangOrthopedic Hospital, Guangzhou General Hospital of Chinese PLA, Guangzhou Guangdong, 510010, P.R.China.
Zefeng LinOrthopedic Hospital, Guangzhou General Hospital of Chinese PLA, Guangzhou Guangdong, 510010, P.R.China.
Xiangling YeOrthopedic Hospital, Guangzhou General Hospital of Chinese PLA, Guangzhou Guangdong, 510010, P.R.China.
Yongqiang ZhangOrthopedic Hospital, Guangzhou General Hospital of Chinese PLA, Guangzhou Guangdong, 510010, P.R.China.
Yuanjun XiaOrthopedic Hospital, Guangzhou General Hospital of Chinese PLA, Guangzhou Guangdong, 510010, P.R.China.yuanjunxia@aliyun.com.
Hong XiaOrthopedic Hospital, Guangzhou General Hospital of Chinese PLA, Guangzhou Guangdong, 510010, P.R.China.
Qingshui YinOrthopedic Hospital, Guangzhou General Hospital of Chinese PLA, Guangzhou Guangdong, 510010, P.R.China.
421 Hospital of PLA · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the osteogenic effect of dextran sulfate/recombinant human bone morphogenetic protein 2/chitosan (DS/rhBMP-2/CS) combined with coralline hydroxyapatite (CHA) in repairing large segmental bone defects by radiographic feature. Methods: Fifty-seven 24-week-old male New Zealand rabbits were prepared for establishing right radius bone defect model of 20 mm in length. In which 54 rabbits were randomly divided into 3 groups ( Results: The experimental animals recovered well and were in normal condition. X-ray observation showed that the bone healing in group B was better than that in groups A and C at each time point. At each time point after operation, the X-ray scores of group B were significantly higher than that of group A and group C ( Conclusion: The osteogenic effect of DS/rhBMP-2/CS/CHA sustained-release artificial bone is much better than that of single CHA and rhBMP-2/CHA, which can provide a new idea for treating bone defect by using bone tissue engineering in the future.

Indexed as

Bone Morphogenetic Protein 2Bone RegenerationChitosanDextran SulfateDurapatiteMicrospheresTissue EngineeringAnimalsAnthozoaHumansHydroxyapatitesMaleOsteogenesisRabbitsRecombinant ProteinsTransforming Growth Factor betaBone Morphogenetic Protein 2ChitosanDextran SulfateDurapatiteHydroxyapatitesRecombinant ProteinsTransforming Growth Factor betabone defectchitosancoralline hydroxyapatiteDextran sulfateradiologyrecombinant human morphogenetic protein 2

Identifiers

PMID29798596
PMCPMC8632580
OpenAlexW3024804905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.